Calaméo - Where Paris January 2020 (#312)
BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers. - Abstract - Europe PMC
Genome‐wide analysis of hybridization in wild boar populations reveals adaptive introgression from domestic pig - Mary - 2022 - Evolutionary Applications - Wiley Online Library
Vétérinaire Anne Salomon - Molsheim
Salomon Anne Molsheim - Vétérinaire (adresse, avis)
L'Institut Curie veut prendre en charge tous les cancers féminins - Challenges
Bérengère OUINE | Institut Curie, Paris | Département de Recherche Translationnelle | Research profile
Oncostatin M is overexpressed in skin squamous-cell carcinoma and promotes tumor progression - QIMA Life Sciences
BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers. - Abstract - Europe PMC
Dr Anne Salomon : Vétérinaire Molsheim 67120 (adresse, horaire et avis)
Bulletin de l'Académie Vétérinaire de France - Persée
Willoughby Animal Hospital | Langley BC
BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers
Improving breast cancer sensitivity to paclitaxel by increasing aneuploidy
vétérinaire Salomon Anne Agenda en ligne vétérinaire
On est en direct": Anne Nivat s'agace sur l'affaire Bourdin - L'ABESTIT
Report of the FEI Veterinary and Dressage Committees' Workshop
Salomon Anne Molsheim Vétérinaire 67120, téléphone et avis
Auteur - Dr Anne VINCENT-SALOMON
ᐅ Horaires d'ouverture „Dr Anne Salomon - Vétérinaire“ | 15 Place de la Liberté à Molsheim
BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers | Science Translational Medicine
Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo - QIMA Life Sciences
Caractérisation des altérations du microbiote respiratoire et investigation des sous-populations de macrophages impliquées da
2022 National Veterinary Scholars Symposium
8p22 MTUS1 Gene Product ATIP3 Is a Novel Anti-Mitotic Protein Underexpressed in Invasive Breast Carcinoma of Poor Prognosis | PLOS ONE
HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast | Journal of Hematology & Oncology | Full Text
